-Live Mint Developments a part of reforms initiated after apex court’s intervention to amend Drugs and Cosmetics Act The health ministry has tightened the norms for clinical trials by making it mandatory for companies to compensate patients who may suffer injury or death while participating in the trials even if they have not been caused by the drugs being tested. So far, the compensation has been restricted only to cases where the...
More »SEARCH RESULT
Total Matching Records found : 1516
Don’t join retail queue but cut diesel taxes, Moily tells States-Sujay Mehdudia
-The Hindu OMCs will revise price every month until losses are wiped out The Centre is seized of some State governments’ directive to their transport undertakings (STU) to line up at retail outlets for refuelling following the removal of subsidy for bulk consumers of diesel, Petroleum Minister M. Veerappa Moily said on Friday. Talking to reporters here, Mr. Moily said he had heard that States such as Gujarat and Tamil Nadu had asked...
More »Pharma MNCs use RTI law to protect market for patented drugs & delay entry of generics
-The Economic Times Pharmaceutical multinationals have begun using the Right to Information law to launch pre-emptive legal action against local generic players to protect the market of patented drugs and delay the entry of low cost generic medicines in the 60,000-crore domestic drug market. MNCs are using such information to sue generic firms even at a stage when their marketing approval is still pending or during the few months' window between the...
More »The great number fetish-Sankaran Krishna
-The Hindu One of the most prominent features of India’s middle-class-driven public culture has been an obsession about our GDP growth rate, and a facile equation of that number with a sense of national achievement or impending arrival into affluence. In media headlines, political speeches, and everyday conversations, the GDP growth rate number — whether it is five per cent or eight per cent or whatever — has become a staple...
More »Prescribe generic drugs: MCI to doctors -Rupali Mukherjee
-The Times of India MUMBAI: The Union government and regulatory bodies appear to be serious in ending the pharma-doctor nexus and curb unethical marketing practices. In its latest effort, the Medical Council of India has directed doctors, hospitals and medical colleges to prescribe generic medicines as far as possible. Generic medicines are more affordable versions of branded medicines sold by companies. In its directive dated January 21 to the principals of medical...
More »
